MEDIVANCE LTDActive

Company number 08142263Private limited companyIncorporated 2012

Key figures

−£8,991-205.6%
Net assets 2024/25
-20 k020 k40 k60 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, MEDIVANCE LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
050 k100 k2019/202020/212021/222022/232023/242024/25

Dividends

from the accounts
2020/21

Dividends paid in the financial year: £37,000 (49% of the profit for the year).

Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Turnover133,537————
Profit for the year75,171————
Cash at bank and in hand54,393————
Total assets83,04355,33712,74314,15315,435
Total liabilities25,21310,72611,55216,58524,426
Net assets / total equity57,83044,6111,191-2,942-8,991
Average number of employees01111
Dividends paid37,000————

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: MEDIVANCE LTD

Company

MEDIVANCE LTD is a private limited company registered with Companies House under company number 08142263. It was incorporated on 13 Jul 2012. Its status is active. The registered office is in London (KT9). Its nature of business (SIC 2007) is general medical practice activities (86210).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Jul 2025); the company files micro-entity accounts. Net assets were −£8,991, down 205.6% on the previous year. Total assets were £15,435 and total liabilities £24,426. The company had an average of 1 employee. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Apr 2027. The next confirmation statement is due by 14 Aug 2027.